BHV-3500

zavegepant · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BHV-3500, covering 2023-03-16 to 2023-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine [Phase 2, Phase 3]